Spero Therapeutics (SPRO) Receivables - Other (2016 - 2026)
Spero Therapeutics (SPRO) recorded Receivables - Other of $44,000 in Q1 2026, down 93.4% from $668,000 a year earlier but up 57.1% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Receivables - Other (2016 - 2026) Analysis & Trends
At the end of FY2025, Spero Therapeutics reported Receivables - Other of $28,000, down 99.1% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of -65.0% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $3.09 million in FY2024 (+99.7%), $1.55 million in FY2023 (+42.5%), $1.08 million in FY2022 (-59.0%) and $2.64 million in FY2021 (-50.5%).
- Quarterly Receivables - Other has ranged from $28,000 in Q4 2025 to $5.02 million in Q1 2024 over the past five years.
- On a year-over-year basis, Receivables - Other has declined for five consecutive quarters, with an average decline of 19.0% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 227.0% in Q3 2023, against a decline of 99.1% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $28,000 (Q4 2025), $1.59 million (Q3 2025) and $2.46 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 668,000.00 |
| Dec 31, 2024 | 3.09 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 4.73 Mn |
| Mar 31, 2024 | 5.02 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 914,000.00 |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.24 Mn |
API Access
Spero Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();